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Is the nihilistic approach to surgical reduction of
superficial and perforator vein incompetence for
venous ulcer justified?
Mark D. Iafrati, MD, Gary J. Pare, MD, Thomas F. O’Donnell, MD, and James Estes, MD, Boston, Mass
Objective: Twenty-five years ago, the senior author showed a 55% postoperative ulcer recurrence rate after open perforator
ligation. Those data contributed to a nihilistic attitude toward incompetent perforating veins. Conversely, since the
introduction of subfascial endoscopic perforator surgery (SEPS), we have undertaken ablation of superficial and
perforator reflux as initial treatment in patients with ulcers (C6) or healed ulcers (C5). This report outlines our long-term
results.
Methods: Between December 1994 and November 1999, SEPS was performed on 51 limbs in 45 patients with C5/C6
disease. Sixteen limbs underwent SEPS alone, and 35 had additional surgery on the greater saphenous vein (GSV), the
lesser saphenous vein, or the tributary varicies. Data were collected according to the reporting standards in venous disease.
Preoperative duplex scan of deep, superficial, and perforating veins was performed. Data were analyzed with Kaplan-
Meier method, Mantel-Cox log-rank test, or t test.
Results: Of the 51 limbs that underwent SEPS, the GSV was stripped in 28. Twenty-nine were C6, and 22 were C5.
Etiology was primary (Ep) in 25 limbs and secondary (Es) in 26 limbs. All limbs had duplex scan evidence of perforator
incompetence (Ap), and deep insufficiency (AD) was seen in 39 cases (76%). Reflux predominated (PR). The clinical
follow-up period was 0 to 82 months (median, 38 months). Venous disability scores improved from 9.8 before surgery to 4.2
at last follow-up (P < .05). Kaplan-Meier analysis showed 74% healing at 6 months. The presence of an ulcer more than 2 cm
in diameter, secondary etiology, and SEPS without concomitant GSV stripping were associated (P < .05) with delayed healing.
Among patients in whom ulcers healed or who were seen with healed ulcers, the 5-year ulcer recurrence rate was 13%. Lesser
saphenous vein reflux was the only factor that correlated with increased ulcer recurrence. Deep system reflux as measured with
duplex scan valve closure times did not correlate with the rate of ulcer healing or recurrence.
Conclusion: Nihilism has no place in the management of venous disease in the 21st century. An aggressive approach to
superficial and perforating vein reflux in this cohort of patients with C5 and C6 disease resulted in rapid ulcer healing and
low 5-year recurrence rates. Prior saphenous vein stripping, large ulcers, and secondary etiology were associated with
delayed healing. A less aggressive posture toward lesser saphenous vein reflux contributed to a higher recurrence rate in
this subgroup of patients. These risk factors are useful in counseling patients as to their expected postoperative course;
however, no combination of factors should a priori preclude surgical intervention in this group of patients. (J Vasc Surg
2002;36:1167-74.)
At the turn of the last century, Homans1 described the
pathophysiologic interaction of the deep, superficial, and
communicating venous systems. Later, Linton2 empha-
sized the significance of incompetent perforating veins and
developed a technique for perforator ligation with a long
medial calf incision. Twenty-five years ago, with the Linton
technique for perforator vein ligation, the senior author
reported a 100% ulcer recurrence rate within 5 years in
postthrombotic limbs compared with 6% in limbs with
normal deep venous systems, concluding “local surgery to
the perforating veins in postphlebitic limbs was shown to be
ineffective.”3 Despite subsequent evidence of a pivotal role
for incompetent perforating veins in symptomatic chronic
venous insufficiency (CVI)4,5 and refinements of the open
technique,6 wound breakdown resulting in patient discom-
fort and disability, and a 40% ulcer recurrence rate, has
limited acceptance of perforator ligation and fostered a
generally nihilistic approach to the surgical management of
CVI.
In recent years, endoscopic techniques for perforator
ligation have been developed.7-10 With videoscopy, these
less invasive approaches use incisions in the upper calf to
gain access to lower calf perforating veins, thereby avoiding
incisions in the lipodermatosclerotic tissues to minimize
wound complications. Subfascial endoscopic perforator
surgery (SEPS) has been shown to be technically feasible
with low perioperative morbidity, short hospital stays, and
reasonable costs.10,11 When compared directly with open
perforator ligation, SEPS was shown to be significantly less
morbid.12
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The North American SEPS (NASEPS) registry re-
ported the early and mid-term results of 146 patients
undergoing SEPS at 17 centers. They found effective ulcer
healing 88% at 1 year but high recurrence rates: 28% at 2
years with a particularly poor outcome for secondary etiol-
ogy (46% at 2 years).13 Because of the relative short fol-
low-up in NASEPS, the limitations of registry data, and the
lack of level 1 to 3 data in the literature, we sought to
explore our long-term results with SEPS alone and in
combination with stripping of the greater saphenous vein
(GSV) and lesser saphenous vein (LSV) and avulsion of
nontruncal varicosities.
METHODS
Between December 1994 and November 1999, SEPS
was performed on 51 limbs in 45 patients with CEAP
classification 5 or 6 disease (active or healed venous ulcer-
ation). Data were collected according to the reporting
standards in venous disease and retrospectively analyzed.14
We use a treatment algorithm in which surgical candidates
with severe CVI (C5 or C6) typically undergo treatment of
all superficial and perforating vein reflux as the initial sur-
gical approach. To this end, preoperative duplex scan stud-
ies were routinely performed. Duplex scan–derived valve
closure time (VCT) assessment of the superficial femoral
vein, popliteal vein, saphenofemoral junction, LSV, and
distal thigh GSV were obtained with the rapid cuff deflation
technique, which was described by van Bemmelen et al.15
Patients were examined in the standing position with an
ATL HDI 3000 or Ultramark 9 duplex scanner (Advanced
Technologies Laboratory, Bothell, Wash) while their
weight was supported on the contralateral leg. For evalua-
tion of the superficial femoral vein and the saphenofemoral
junction, an automated 24-cm thigh cuff was inflated to 80
mm Hg for approximately 3.0 seconds and then rapidly
deflated within 0.3 seconds. In evaluation of the popliteal
vein and distal thigh GSV, a 12-cm cuff was applied to the
calf, inflated to 100 mm Hg, and rapidly deflated. The
distance between the cuff and the transducer was always less
than 5 cm. Spectral analysis was recorded and later used to
quantify the VCT. Valvular incompetence was considered
to be present if the reflux time exceeded 0.5 seconds.15
Incompetent perforating veins were identified with both
physical examination and duplex scan study in the upright
position. Perforating veins were defined as vessels that
penetrate the fascia and are continuous from the superficial
to the deep venous systems. Duplex scan examination was
routinely performed over the medial and posterior calf, and
interrogation of the anterolateral calf or thigh was per-
formed as clinically indicated. Perforating veins were ob-
served at the point they traversed the fascia. Manual calf
compression above and below the transducer was per-
formed, and perforating veins were considered incompe-
tent if there was outward flow only or if reflux time ex-
ceeded 0.5 seconds.16,17 The cuff deflation technique was
not applicable here because the transducer must be moved
along the leg. During this duplex scan examination, obvi-
ous deep venous obstruction was noted; however, formal
analysis of wall thickening and compressibility was not
undertaken. Early in the study period, phlebograms were
routinely obtained. However, duplex ultrasound scan has
greatly reduced the frequency of invasive testing in our
practice recently. We classified patients as having second-
ary etiology if they had a history of deep venous throm-
bosis and treatment with anticoagulation or if their
history and vascular studies strongly suggested the diag-
nosis.
Surgical intervention was formulated to correct super-
ficial and perforating vein reflux. Accordingly, the GSV was
ligated and stripped to the knee when found to be incom-
petent.18 A less aggressive posture was taken in regard to
the lesser saphenous, which was typically treated only if
grossly dilated or in the presence of lateral calf ulcerations
and then only with ligation. Incompetent perforating veins
were ligated with direct cut down when located in the thigh
or anterolateral calf or with a subfascial endoscopic ap-
proach when identified in the medial or posterior calf. SEPS
was performed with a two-port technique with CO2 insuf-
flation and exsanguination with tourniquet control as pre-
viously described.19,20 The subfascial dissection was guided
with the preoperative duplex scan; however, endoscopic
inspection of the entire medial and posterior superficial
posterior compartment was routinely performed. During
the course of this surgical series, the use of paratibial
fasciotomy became routine rather than selective and work-
ing port location moved distally toward the mid calf but
never into lipodermatosclerotic tissues. All patients re-
ceived regular follow-up in the vascular clinic and were
prescribed compression garments after surgery, but com-
pliance was not assessed.
Data were analyzed with Stat View for Windows 5.0.1
(Berkeley, Calif). Ulcer healing and recurrence data were
assessed with actuarial estimates made according to Kaplan-
Meier technique, Mantel-Cox log-rank test was used for
subgroup comparisons, and Cox regression models were
used for assessment of the impact of VCT data. Descriptive
statistics are presented as the mean  the standard error of
the mean (SEM). Venous disability scores were not nor-
mally distributed and were analyzed with the Wilcoxon
signed rank test. Statistical significance was assigned at a P
value of .05 or less.
RESULTS
Our group performed SEPS on 51 limbs in 45 patients
with CEAP classification 5 or 6 CVI during a 5-year period
from 1994 to 1999. The 28 men and 17 women had a
median age of 58 years (range, 38 to 78 years). Patient
preoperative status was described according to the report-
ing standards in venous diseases.14 History, physical exam-
ination, duplex ultrasound scan, and phlebography were
considered in assignment of CEAP classification. Table I
(online only) contains the CEAP classification for each
operated limb and demographic and follow-up data. Table
II (online only) depicts the values for VCTs at each exam-
JOURNAL OF VASCULAR SURGERY
December 20021168 Iafrati et al
ined vein segment. In summary, at the time of surgery, 29
limbs were ulcerated (C6) and 22 had healed ulcers (C5).
Primary venous insufficiency (Ep) was noted in 25 limbs,
and secondary etiology (Es) was documented in 26 limbs
with either history of therapy for deep venous thrombosis
or history and imaging studies consistent with the diagno-
sis. All limbs had duplex scan evidence of incompetent
perforating veins (Ap) in the medial calf, and deep venous
insufficiency (AD) was seen in a high proportion 39 (76%).
Significant axial or tributary superficial venous insufficiency
was noted in 35 limbs and was surgically addressed at the
time of SEPS. The GSV was stripped in 28 limbs, LSV
ligated in seven limbs, and isolated tributary avulsions
without GSV or LSV in two limbs. The number of perfo-
rating veins encountered at surgery was three to 10, with a
median of five. Because procedures were performed with
tourniquet control, no intraoperative assessment of incom-
petence was possible.
The clinical follow-up period ranged from 0 to 82
months (median, 38 month; SEM, 3.4 months). Venous
disability scores14 improved from 9.7 (n  43; SEM, 0.6)
before surgery to 4.2 (n  46; SEM, 0.6) at last follow-up
(P  .05). Kaplan-Meier analysis showed 74% healing at 6
months (Fig 1; Table III, online only). The presence of an
ulcer of more than 2 cm in diameter (Fig 2, A; Table IV,
online only), ES or postthrombotic etiology (Fig 2 , B;
Table V, online only), and the absence of concomitant GSV
stripping (Fig 2 , C; Table VI, online only) were associated
(P  .05) with delayed healing. No other demographic or
anatomic factors, including initial CEAP classification, sig-
nificantly impacted time to healing. Considering the best
and worst case scenarios of patients with all or none of these
factors, four limbs with all three good prognostic factors
healed within 1 month; of eight limbs with all three nega-
tive factors, four never healed; and the 6-month healing
rate was only 37%.
Time at risk for recurrence was calculated from the day
of surgery for C5 limbs and from the date of initial healing
in C6 limbs. The 5-year ulcer recurrence rate was 13% (Fig
3; Table VII, online only). LSV reflux was the only factor
that correlated with increased risk of recurrence (P 
.005). The recurrence rates for primary and secondary
etiology at 5 years were 18% versus 6% (standard error,
10%; P .6). Neither the presence of deep system reflux
nor the duration of reflux as measured with duplex scan
VCTs significantly influenced the rate of ulcer healing or
recurrence.
No deaths or cardiac, thromboembolic, or other systemic
complications occurred. There were no infections, one trocar
site broke down, and one (2%) calf hematoma required reex-
ploration. The calf hematoma was in a patient who had
undergone SEPS with paratibial fasciotomy and resulted from
an avulsed branch of the posterior tibial artery.
DISCUSSION
To date, approximately 1000 SEPS cases have been
reported in the world literature, with no reported fatalities
Fig 1. C6 healing time: Kaplan-Meier plot of time to heal for ulcers versus month. Dashed line represents SEM 10%.
JOURNAL OF VASCULAR SURGERY
Volume 36, Number 6 Iafrati et al 1169
Fig 2. A, Time to heal versus ulcer size: Kaplan-Meier plot of time to heal for ulcers versus ulcer size. B, Time to heal
versus etiology: Kaplan-Meier plot of time to heal for ulcers versus etiology of venous insufficiency. Primary venous
insufficiency versus secondary insufficiency (postthrombotic). C, Time to heal versus GSV stripping: Kaplan-Meier plot
of time to heal for ulcers versus concomitant GSV stripping.
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and acceptable morbidity. Despite the established safety
of the SEPS technique, debate still surrounds the role of
perforator vein incompetence in the pathophysiology of
CVI. Although few would take issue with the thesis of
Homans1 on the relationship of the deep, superficial, and
perforating veins of the leg, the relative importance of each
and the impact of surgical treatments on patient outcome
remain unsettled. With duplex ultrasound scan, Stuart et
al21 found that worsening CEAP grade of CVI is associated
with an increase in the number and diameter of medial calf
perforating veins, particularly those permitting bidirec-
tional flow. Rhodes et al22 documented improved venous
hemodynamics after SEPS, thereby implying a significant
role for perforator ligation. However, as in our series, SEPS
is commonly performed in conjunction with superficial
venous ablation and discerning the impact of SEPS on the
overall outcome is challenging. Surgical correction of su-
perficial reflux without perforator ablation has also been
shown to improve venous hemodynamics and to reduce
perforator reflux.23 However, in a series of patients with C5
to C6 disease undergoing superficial ablation, Padberg et
al24 failed to show improved deep system reflux with duplex
scan. Their patients had severe grade 3 to 4 phlebographic
reflux, suggesting that irreversible damage may have oc-
curred in the deep venous system before surgery. Although
a number of centers have published short-term clinical
results11,12,22,25-30 and a North American Registry13 re-
corded the early experience in the United States, there has
only been one prospective randomized trial. That small
study of 35 patients from Australia randomized patients to
superficial venous surgery with or without SEPS and was
unable to show early clinical or hemodynamic differenc-
es.31 Ultimately, resolution of the hemodynamic and clin-
ical consequences of SEPS will await the results of robust
prospective randomized trials.
Our manuscript outlines the results of a relatively ag-
gressive surgical approach to the eradication of superficial
and perforating venous insufficiency in patients with severe
CVI (C5 to C6). During the study period, approximately
one third of all venous operations included SEPS either
alone or in combination with other procedures. We typi-
cally reserve deep venous reconstruction for patients with
failed superficial venous ablation. The tertiary nature of our
practice may account for the large percentage of patients
with DVI (76%), secondary etiology (50%), and ulcers of
more than 2 cm (54%). However, despite these generally
accepted adverse prognostic factors, we found a 1-year
healing rate of 74%. Our ulcer healing rate is slightly less
than the reported 88% 1-year NASEPS data. Like NASEPS,
we found concomitant saphenous stripping to correlate
with enhanced healing. This statistically significant effect
reflects both the marked hemodynamic impact of stripping
an incompetent saphenous vein and also the fact that most
patients not undergoing concomitant GSV stripping had
undergone previous venous operations and therefore rep-
resent a group with failed previous venous surgery. Al-
though NASEPS identified obstructive pathophysiology as
a significant adverse factor, we only encountered three
C6Po,R limbs and cannot draw valid conclusions in that
regard. In addition to concomitant GSV stripping, we also
Fig 3. Time to recurrence. Kaplan-Meier plot of time from operation to recurrence for patients with C5 disease, from
date of healing to first recurrent ulcer in patients with C6 disease.
JOURNAL OF VASCULAR SURGERY
Volume 36, Number 6 Iafrati et al 1171
found that ulcer size and secondary etiology correlated
with ulcer healing. When comparing the four C6 limbs
with all three statistically significant attributes identified
with our analysis (GSV stripping, Ep, and ulcer  2 cm)
with the eight limbs with all three negative factors, we
found a 6-month healing rate of 100% versus 37%. This
information is useful in counseling patients before sur-
gery as to reasonable expectations for surgical interven-
tion on the basis of their clinicopathologic status at
presentation.
Ulcers recurred in patients with C5 or C6 disease after
healing in only five of 44 at-risk limbs, yielding a 5-year
actuarial recurrence rate of 13%. This recurrence data com-
pares favorably with the NASEPS 2-year recurrence rate of
28%. Furthermore, whereas secondary etiology was associ-
ated with an even higher 46% 2-year recurrence rate in
NASEPS,13 we found no significant impact of secondary
etiology on recurrence. This difference is in part accounted
for by a better initial healing rate in NASEPS and a lower
prevalence of occlusive pathology in our series. However,
we believe that our uniform and aggressive approach to the
elimination of superficial and perforator reflux has contrib-
uted to these durable results.
The only factor that correlated with ulcer recurrence
was the presence of lesser saphenous reflux on preoperative
duplex scan examination. The lesser saphenous was typi-
cally treated only if it was grossly dilated or in association
with lateral ulcerations. Because all of the reported proce-
dures included SEPS, they were performed in the supine
position, making access to the LSV at times difficult. In
addition, marking of the saphenopopliteal junction was not
consistently achieved before surgery. Finally, in an effort to
minimize the risk of sural nerve injury, we routinely ligated
rather than stripped the LSV. These factors all contributed
to incomplete treatment of LSV reflux and the observed
increase in ulcer recurrence rate.
This report describes long-term results of a nonran-
domized single-center experience that incorporated SEPS
in the treatment of patients with C5 and C6 disease with
perforating vein incompetence. Because of the limitations
of this study design, we were unable to differentiate the
effect of SEPS versus superficial venous ablation on out-
come. The answer to this fundamental questions awaits a
robust prospective randomized trial. Despite these limita-
tions, these data strongly support the conclusion that nihil-
ism has no place in the management of venous disease in the
21st century. An aggressive approach to superficial and
perforating vein reflux in this cohort of patients with C5
and C6 disease resulted in rapid ulcer healing and low
5-year recurrence rates. Prior saphenous vein stripping,
large ulcers, and secondary etiology were associated with
delayed healing. These risk factors are useful in counseling
patients as to their expected postoperative course; however,
we did not identify any combination of factors that should
a priori preclude surgical intervention in this group of
patients.
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DISCUSSION
Dr Karl A. Illig (Rochester, NY). That was a very nicely
presented talk, and I appreciate the opportunity to discuss this
paper.
SEPS, I think, as people who are involved in venous disease
know, is a surprisingly beleaguered procedure. The problem is that
the underlying problem, chronic venous disease, is very diverse,
both in manifestation and in procedures needed to get this taken
care of. At the 2000 Venous Forum, a ban was essentially placed on
any mention of SEPS short of a prospective randomized trial. And
this seems to have worked, at least if you look at the citations in
Yearbook of Vascular Surgery. In 2000, there was a mention or
two, but one paper was given a “whiff of camel dung”; in 2001, the
two papers cited elicited an amazing amount of frothing at the
mouth by the senior author at that point; and in this year’s
Yearbook, which arrived a couple days ago, there is no mention of
SEPS even in the index, let alone the book itself.
SEPS has been referred to as “Surgery Escaping Proper Scru-
tiny.” My own personal bias is that it is a “Substantially Effective
Procedure Squelched.” The two exceptions to this enforced silence
are obviously the groups from Mayo Clinic and New England
Medical Center, Peter Gloviczki and Tom O’Donnell, respec-
tively, to whom those of us who do venous disease are quite
grateful.
The current paper, which was very nicely presented today by
Dr Pare, describes the results at NEMC in the 51 limbs operated
on over the past 6 years for active or healed ulcerations (C5 to C6
disease only). They documented a 74% healing rate at 6 months
and a 5-year recurrence rate of only 13% with good follow-up.
These results are obviously quite good whether you compare them
with the North American SEPS Registry, other series that are out
there, or, to be fair, cohorts of patients treated nonoperatively as
well.
And intriguingly, the results are much better than the senior
author’s own series of 25 years ago following open perforator
ligation. Obviously, like any good study, you could ask a thousand
different questions, but in the interest of time and clarity I am
going to limit them to just three.
First of all, you report the outcome here in 51 limbs with active
or healed ulceration only. What are your results in the rest of your
patients? Have you had any new ulcers, for example, in C4 patients?
Second is the issue of postphlebitic patients. This issue is
obviously pretty salient. It has been addressed by the Mayo Clinic
recently, with results being somewhat equivocal, while in your own
series the postphlebitic legs had a slower healing rate but no
differences in terms of recurrence. My question to you is, do you
think postphlebitic legs really do fare worse in terms of healing than
those with primary incompetence and, as a result, what is your
attitude and workup in these patients?
Finally, and most importantly, is the obvious question.
Whether you do it using an open Linton procedure or via endo-
scopic techniques, you are still, in theory, ligating the perforators.
How do you account for the vastly improved results in 2002 versus
those reported in the original Burnand-O’Donnell series from the
mid 1970s?
I want to thank you very much for the privilege of reviewing
and discussing this interesting paper. I do want to congratulate you
on figuring out that the meeting was actually in May rather than
later, as apparently you did a couple of days ago, and compliment
you on a very nice presentation given the circumstances. I defi-
nitely share your belief that an aggressive approach toward treat-
ment of chronic venous disease is appropriate in the 21st century.
Dr Gary J. Pare. Thank you very much for the comments on
our work.
Our experience, right now, is that we mainly limit our SEPS
procedures to C5 and C6 patients at New England Medical Cen-
ter. So the question regarding the C4 patients, I do not have any
experience with doing SEPS procedures on C4 patients, so I
cannot answer the question whether there have been any ulcers
after our SEPS procedure.
The second question is regarding the etiology, and primary
versus secondary etiology, and we have we found that the second-
ary etiology patients do worse. As mentioned earlier, the time to
heal was significantly less in the secondary etiology group. How-
ever, that does not prohibit us from offering the SEPS procedure.
We do not screen based on etiology. So, whether it is a primary or
a secondary etiology, we will offer the SEPS procedure.
Finally, the last question, which I anticipated, was a question
regarding Dr O’Donnell’s paper from St Thomas Hospital. It was
a paper from St Thomas Hospital in 1976 by Drs O’Donnell,
Burnand, and Browse, looking at the open procedure and regard-
ing the 100% recurrence rates in people with deep venous abnor-
malities.
In going back, and after talking with Dr O’Donnell, when
Linton originally described his open procedure, it does not show
up great here, but the paratibial fascia is clearly open here to get the
deep posterior compartment perforators, which in the study of
1976 was not opened, the paratibial fascia was not taken down.
And if you look at this slide, you can see this is the percent of
perforating veins accessible and this is at different levels of the calf.
And as you can see, at different levels of the calf, the accessibility of
the perforating veins changes. In the mid calf, about 85% of the
perforating veins will be identified just opening the superficial
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posterior compartment. However, at the upper calf and the lower
calf, you can miss a significant amount of perforating veins. And so
I think that our experience taking down the peritibial fascia to
identify perforating veins has improved our results and we now
know where to look for them.
Dr Theodore R. Sullivan (Abington, Pa). When I was a
fellow working with Dr O’Donnell a few years back, in trying to
work out some of the technical problems associated with the SEPS
procedure, I was impressed by the difficulty of getting at the
perimalleolar perforators, those very distal perforators where often-
times the venous ulceration problem is the worst. In your study,
did you consider looking at the duplex identification of perforators
pre and post SEPS to see if you in fact obliterated the perforators
that you identified preoperatively? Was there any correlation, if you
did, with healing or treatment failure?
Dr Pare. Unfortunately, our postprocedure valve closure
time follow-up studies are fairly limited and we are in the process of
trying to get people back to repeat the VCT studies to see if there
are missed perforators and to see if we can correlate that with ulcers
that have not healed. So it is a good question. It is difficult to get
down to the perforators down near the malleolus, and we do our
best, but I think that technically it is very difficult to get those. So,
we are awaiting more follow-up data regarding the missed perfo-
rators.
Dr Stanley A. Hirsch (Pittsburgh, Pa). How many of your
patients wore compression stockings postop? And if they did, do
you think that is what kept your ulcer recurrence rate low? Did you
have a compliance problem with the use of stockings? That is really
a great problem in my experience.
Dr Pare. Unfortunately, we do not have a limb of this study
where we looked at conservative management and ulcer healing
with only conservative management. As far as the compliance
postoperatively, I think that our overall compliance was probably
about 75%; and I would say that probably 50% continued wearing
stockings after the surgery for some time period. And once again,
unfortunately, this is going back a few years, but as well as I could
tell from the information from charts, that was the issue. So, there
certainly could be a component of conservative management post-
operatively, but anecdotally it looks like we got better healing than
compared with our patients that we managed only conservatively.
Dr Frank T. Padberg (Boston, Mass). Gary, congratulations
again for bringing us meaningful results and a demonstration that
allows renewed encouragement for surgical management of
chronic venous insufficiency. I think it is fair to say that there is a
consensus of opinion, as demonstrated and corroborated by your
data, that surgical correction of superficial incompetence for pri-
mary reflux and severe chronic insufficiency is beneficial.
The major problem here is in retraining ourselves to look for
such fixable or repairable problems in the patient populations that
show up in our clinics with the venous ulcer and get ignored for
years.
I think the controversial issues here, however, involve opera-
tive intervention for two specific subsets, which you have ad-
dressed. One of those is the isolated perforator, and I would like for
you to go into a little greater detail as to how you select the patients
that had only SEPS procedures for these presentations.
And secondly, superficial and perforator disease for the post-
thrombotic limb. Dr Illig asked you about that, and I would like
for you to specify a bit more which patients you might reject who
had postthrombotic disease and presence of ulceration. I doubt
that you are operating on everyone who has perforator incompe-
tence and postthrombotic disease, and how do you select that
patient from amongst those who you think are likely to benefit?
And finally, one last question, which is more of a comment, we
presented some data regarding sensory impairment in the area of
the ulcer and associated that with recurrence at this year’s Venous
Forum, and I was wondering if you adopted that as part of your
protocol?
Dr Pare. I will start with the second question regarding who
we choose to do SEPS procedures on and people with postphle-
bitic changes. We take a very aggressive approach at New England
Medical Center where we do not screen based on whether it is a
primary or secondary etiology. Essentially, if there is greater saphe-
nous vein incompetence and there are perforating veins that are
incompetent based on our VCT studies, then we go ahead and
correct the superficial system first and basically close follow-up and
see what happens after we correct the superficial. If there are
further problems afterwards, then we may take a more aggressive
approach such as vein valve transplant. But we take a very aggres-
sive upfront approach and take care of all the superficial disease
initially and that is based on our VCT studies.
I did not look at any of the sensory impairment data that you
asked, so I cannot answer that question.
And I am sorry, if you could repeat the first question.
Dr Padberg. The isolated perforator, again, this is the post-
thrombotic patient. I assume from your reply that when you say
correcting the superficial, you are including the perforator resec-
tion in that; is that correct?
Dr Pare. Yes, absolutely.
Dr Steve Elias (Englewood, NJ). I congratulate you for
keeping SEPS in the picture. We are also aggressive at Englewood;
we average around 25 SEPS per year.
My question, one, in those patients even though you said were
not necessarily significant that you took care of saphenous incom-
petence and stripped the saphenous and did not, the ones that you
did not, was the reason that the saphenous was a competent vein or
they were an incompetent saphenous and you just elected not to
deal with it?
And secondly, in these ulcer patients, when do you go to the
next step; in other words, those large ulcers that you know are
perhaps not going to heal, when do you consider, once you have
ablated your venous incompetence, doing skin grafting or other
adjunctive procedures?
Dr Pare. If on our preoperative VCT study, we have an
incompetent greater saphenous vein that gets stripped in the
operating room. We do not screen. Basically, any superficial disease
is taken care of, saphenous vein stripping, perforator surgery.
Typically, we now have a good idea, based on our work here,
that anywhere from 6 to 9 months we should expect healing after
our procedure. If we do not get healing after that, with additional
conservative management, then we will go ahead and offer a more
complex repair.
Dr Fredric Jarrett (Pittsburgh, Pa). Historically, you and
other authors have compared this with the Linton procedure. And
I think it is worth emphasizing two things about this. One is that
what Dr Linton did in his later years was called the modified Linton
procedure, because the original one was a very huge operation with
stripping of the greater and lesser saphenous veins. Nevertheless,
even the modified procedure, which Dr Linton did not do a great
number of, has been largely abandoned by most people today
because of the very high rate of wound complications.
But what was done in the later years was still a radical ligation
of the subfascial veins but also an excision of the ulcer with a skin
graft. And if the ulcer bed is excised down to good tissue and the
perforator incompetence is dealt with, this is still a very effective
procedure for dealing with the ulcer in timely fashion because it
heals up within a week or 2.
However, one of the difficulties with this operation today, in
addition to the wound problems, is that it is virtually impossible to
keep people in the hospital for 7 to 10 days, the way Dr Linton did,
with immobilization of the leg in a splint and allowing the skin
graft to heal.
But I think there a lot of important messages in this paper,
which has been very carefully and well done, but I think one of the
most important of these is that this is multifaceted venous disease
and one needs to deal with the simpler things first, such as the
superficial insufficiency, in order to get good results like you have
done. Thank you very much
Dr Pare. Thank you.
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Table I, online only. Anatomic and demographic data at entry
CEAP Age (y) Gender
Prior GSV
stripping Procedure
Time to heal
(mo)
Time to
recur (mo)
Total
F/U (mo)
C5EPADPPR 54 M No SEPS alone N/A
C5EPASDPPR 52 F No SEPS  GSV N/A 0.70
C5EPASDPPR 78 F Yes SEPS  LSV N/A 9 35.27
C5EPASDPPR 47 M No SEPS only N/A 36.23
C5EPASDPPR 57 M No SEPS  GSV N/A 37.43
C5EPASDPPR 76 F No SEPS only N/A 38.03
C5EPASDPPR 76 F No SEPS  GSV  LSV N/A 38.03
C5EPASDPPR 43 M No SEPS  avulsion N/A 40.90
C5EPASDPPR 49 M No SEPS  LSV N/A 38 17.73
C5EPASDPPR 56 M No SEPS  GSV N/A 39.23
C5EPASPPR 65 F No SEPS  GSV N/A 2.60
C5EPASPPR 62 M No SEPS  GSV N/A 75.10
C5EPASPPR 60 M No SEPS  GSV N/A 48.63
C5EPASPPR 59 F No SEPS  GSV N/A 59.63
C5EPASPPR 53 F No SEPS  GSV N/A 43.90
C5EPASPPR 42 M No SEPS  GSV N/A 1.37
C5EPASPPR 38 M No SEPS  GSV N/A 0.37
C5ESAPPR 73 F Yes SEPS alone N/A 64.57
C5ESASDPPR 48 M Yes SEPS alone N/A 66.10
C5ESASDPPR 59 M No SEPS  GSV N/A 12.70
C5ESASDPPR 63 F No SEPS  GSV N/A 12.60
C5ESASDPPR 49 M No SEPS  GSV  LSV N/A 3.33
C6EPADPPOR 48 M Yes SEPS alone 116 19.77
C6EPADPPR 71 M Yes SEPS alone 179 77.50
C6EPASDPPR 78 F No SEPS  GSV 56 21 36.20
C6EPASDPPR 59 F No SEPS  GSV 8 36.30
C6EPASDPPR 52 M No SEPS  GSV 27 47.77
C6EPASDPPR 49 M No SEPS  GSV 45 38.10
C6EPASDPPR 58 M No SEPS  GSV 56 12.37
C6EPASPPR 63 F No SEPS  GSV 9 49.93
C6EPASPPR 53 M No SEPS  GSV 20 29.50
C6ESADPPOR 72 M No SEPS alone 99 82.07
C6ESADPPR 58 M Yes SEPS alone 232 68.30
C6ESADPPR 54 M Yes SEPS alone 91 11 17.50
C6ESADPPR 56 F Yes SEPS alone Never healed 72.13
C6ESADPPR 56 F Yes SEPS alone Never healed 62.53
C6ESADPPR 62 F No SEPS alone 94 76.83
C6ESAPPR 58 M Yes SEPS alone Never healed 68.30
C6ESAPPR 57 M No SEPS  avulsion 25 62.13
C6ESASDPPOR 59 F Yes SEPS alone 34 36.17
C6ESASDPPR 58 F No SEPS  GSV 173 70.77
C6ESASDPPR 58 M Yes SEPS  LSV Never healed 41.23
C6ESASDPPR 66 M No SEPS  GSV 11 42.30
C6ESASDPPR 63 M No SEPS  GSV Never healed 14.47
C6ESASDPPR 48 M Yes SEPS alone 144 66 66.10
C6ESASDPPR 51 M No SEPS  GSV 19 0.63
C6ESASDPPR 62 F No SEPS  GSV 27 19.77
C6ESASDPPR 62 F Yes SEPS  GSV  LSV Never healed 6.20
C6ESASDPPR 54 M Yes SEPS  LSV 18 32.50
C6ESASDPPR 70 M Yes SEPS  LSV  avulsion Never healed 6.50
C6ESASDPPR 71 F No SEPS  GSV 12 36.60
As, Superficial venous disease; Po, obstructive pathology; Avulsion, avulsion of tributaries; M, male; F, female; N/A, not applicable; F/U, follow-up.
Table II, online only. Venous VCT
CEAP SFJ (s) GSV (s) LSV (s) SFV (s) POP (s)
C5EPADPPR 0.75 0.00 0.00 3.00 4.00
C5EPAPR
C5EPASDPPR N/A N/A 7.50 0.75 6.00
C5EPASDPPR 3.25 3.00 0.00 0.00 3.75
C5EPASDPPR 2.00 5.50 0.00 0.00 0.00
C5EPASDPPR 1.8 1.2 5.2 2 2.2
C5EPASDPPR 1 0.8 0.4 2 0.4
C5EPASDPPR 0.9 1.2 1.4 1.2 1.2
C5EPASDPPR 2.5 1.6 2.6 2 2
C5EPASDPPR N/A N/A 2.4 2.6 3.8
C5EPASDPPR 6 5 0.8 5 1.8
C5EPASPPR 8.00 7.20 0.10 1.00 0.10
C5EPASPPR 5.00 5.50 1.00 0.00 0.00
C5EPASPPR 3.50 6.25 3.50 0.00 0.00
C5EPASPPR 3.00 3.00 1.50 1.00 0.00
C5EPASPPR
C5EPASPPR 1 6.4 0.4 0.4 0.4
C5ESASDPPR 3.60 4.90 3.40 3.60 3.80
C5ESASDPPR 12.00 N/A 5.00 6.60 4.80
C5ESASDPPR
C5ESASDPPR 5 3 2.8 2.2 3.6
C5ESASPPR 8.75 8.00 0.00 1.00 0.00
C6EPADPPR N/A N/A N/A 7.20 10.40
C6EPADPPR 0.10 0.10 0.10 14.00
C6EPASDPPR 5.00 6.50 0.25 1.25 0.00
C6EPASDPPR 5.00 6.50 0.25 1.25 0.00
C6EPASDPPR 4.50 2.75 0.00 0.00 2.25
C6EPASDPPR 1 1.6 4 1.4 2.4
C6EPASDPPR 0.8 1.6 0.6 0.6 2.2
C6EPASDPPR
C6EPASPPR 5.00 5.00 0.00 0.25 0.00
C6EPASPPR 7.75 7.5 0 0 0
C6ESADPPOR N/A N/A N/A 2.60 2.80
C6ESADPPR
C6ESADPPR
C6ESADPPR
C6ESADPPR N/A N/A 0.00 7.00 5.00
C6ESAPPR 0.50 0.50 0.30 0.00 0.20
C6ESAPR
C6ESASDPPOR 0.10 4.60 1.60 5.40 6.40
C6ESASDPPOR
C6ESASDPPR N/A N/A 4.80 5.00 7.00
C6ESASDPPR 6.20 8.20 0.10 0.10 3.40
C6ESASDPPR 9.40 0.40 0.10 10.80 7.00
C6ESASDPPR N/A N/A 1.20 0.30 5.20
C6ESASDPPR 3.00 1.50 0.00 6.50 Obst
C6ESASDPPR 5.50 6.50 0.00 0.00 3.75
C6ESASDPPR 1.00 5.00 0.00 2.00 0.00
C6ESASDPPR N/A N/A 3.00 4.75 0.50
C6ESASDPPR N/A N/A 2.00 7.00 6.00
C6ESASDPPR N/A N/A 5.50 6.00 5.00
SFJ, Saphenofemoral junction; GSV, above-knee greater saphenous vein; SFV, superficial femoral vein; POP, popliteal vein; N/A, not applicable.
Table III, online only. Kaplan-Meier survival table for time to heal for ulcers in C6 limbs
Months Status
Cumulative
healing
Standard
error At risk
0 0 0 27
0.27 Uncensored 0.04 0.04 26
0.3 Uncensored 0.07 0.05 25
0.37 Uncensored 0.11 0.06 24
0.4 Uncensored 0.15 0.07 23
0.6 Uncensored 0.19 0.07 22
0.63 Uncensored 0.22 0.08 21
0.67 Uncensored 0.26 0.08 20
0.83 Uncensored 0.30 0.09 19
0.9 Uncensored 0.37 0.09 18
0.9 Uncensored 0.37 0.09 17
1.13 Uncensored 0.41 0.09 16
1.5 Uncensored 0.44 0.10 15
1.87 Uncensored 0.52 0.10 14
1.87 Uncensored 0.52 0.10 13
3.03 Uncensored 0.56 0.10 12
3.13 Uncensored 0.59 0.09 11
3.87 Uncensored 0.63 0.09 10
4.8 Uncensored 0.67 0.09 9
5.77 Uncensored 0.70 0.09 8
5.97 Uncensored 0.74 0.08 7
6.2 Censored 0.74 0.08 6
6.5 Censored 0.74 0.08 5
7.73 Uncensored 0.79 0.08 4
14.47 Censored 0.79 0.08 3
41.23 Censored 0.79 0.08 2
68.3 Censored 0.79 0.08 1
72.13 Censored 0.79 0.08 0
Table IV, online only. Kaplan-Meier survival table for time to heal for ulcers in C6 limbs; subgroup analysis of limbs
with ulcers of less than 2 cm and more than 2 cm
Months Status
Cumulative
healing
Standard
error At risk
Ulcers 2 cm
0 Uncensored 0 0 12
0.27 Uncensored 0.08 0.08 11
0.3 Uncensored 0.17 0.11 10
0.37 Uncensored 0.25 0.13 9
0.4 Uncensored 0.33 0.14 8
0.63 Uncensored 0.42 0.14 7
0.67 Uncensored 0.50 0.14 6
0.83 Uncensored 0.58 0.14 5
1.13 Uncensored 0.67 0.14 4
1.87 Uncensored 0.75 0.13 3
3.87 Uncensored 0.83 0.11 2
4.8 Uncensored 0.92 0.08 1
14.46 Censored 0.92 0.08 0
Ulcers 2 cm
0 0 0 15
0.6 Uncensored 0.07 0.07 14
0.9 Uncensored 0.20 0.10 13
0.9 Uncensored 0.20 0.10 12
1.5 Uncensored 0.27 0.11 11
1.87 Uncensored 0.33 0.12 10
3.03 Uncensored 0.40 0.13 9
3.13 Uncensored 0.47 0.13 8
5.77 Uncensored 0.53 0.13 7
5.97 Uncensored 0.60 0.13 6
6.2 Censored 0.60 0.13 5
6.5 Censored 0.60 0.13 4
7.73 Uncensored 0.70 0.13 3
41.23 Censored 0.70 0.13 2
68.3 Censored 0.70 0.13 1
72.13 Censored 0.70 0.13 0
Table V, online only. Kaplan-Meier survival table for time to heal for ulcers in C6 limbs; subgroup analysis of limbs
with primary venous insufficiency and secondary venous insufficiency
Months Status
Cumulative
healing
Standard
error At risk
Primary venous insufficiency
0 0 0 8
0.27 Uncensored 0.13 0.12 7
0.3 Uncensored 0.25 0.15 6
0.67 Uncensored 0.38 0.17 5
0.9 Uncensored 0.50 0.18 4
1.5 Uncensored 0.63 0.17 3
1.87 Uncensored 0.88 0.12 2
1.87 Uncensored 0.88 0.12 1
5.97 Uncensored 1.00 0 0
Secondary venous insufficiency
0 Uncensored 0 0 19
0.37 Uncensored 0.05 0.05 18
0.4 Uncensored 0.11 0.07 17
0.6 Uncensored 0.16 0.08 16
0.63 Uncensored 0.21 0.09 15
0.83 Uncensored 0.26 0.10 14
0.9 Uncensored 0.32 0.11 13
1.13 Uncensored 0.37 0.11 12
3.03 Uncensored 0.42 0.11 11
3.13 Uncensored 0.47 0.12 10
3.87 Uncensored 0.53 0.12 9
4.8 Uncensored 0.58 0.11 8
5.77 Uncensored 0.63 0.11 7
6.2 Censored 0.63 0.11 6
6.5 Censored 0.63 0.11 5
7.73 Uncensored 0.71 0.11 4
14.47 Censored 0.71 0.11 3
41.23 Censored 0.71 0.11 2
68.3 Censored 0.71 0.11 1
72.13 Censored 0.71 0.11 0
Table VI, online only. Kaplan-Meier survival table for time to heal for ulcers in C6 limbs; subgroup analysis of limbs
with concomitant GSV stripping and no concomitant GSV stripping
Months Status
Cumulative
healing
Standard
error At risk
GSV stripping
0 0 0 14
0.27 Uncensored 0.07 0.07 13
0.3 Uncensored 0.14 0.09 12
0.37 Uncensored 0.21 0.11 11
0.4 Uncensored 0.29 0.12 10
0.63 Uncensored 0.36 0.13 9
0.67 Uncensored 0.43 0.13 8
0.9 Uncensored 0.57 0.13 7
0.9 Uncensored 0.57 0.13 6
1.5 Uncensored 0.64 0.13 5
1.87 Uncensored 0.79 0.11 4
1.87 Uncensored 0.79 0.11 3
5.77 Uncensored 0.86 0.09 2
6.2 Censored 0.86 0.09 1
14.47 Censored 0.86 0.09 0
No GSV stripping
0 0 0 13
0.6 Uncensored 0.08 0.07 12
0.83 Uncensored 0.15 0.10 11
1.13 Uncensored 0.23 0.11 10
3.03 Uncensored 0.31 0.12 9
3.13 Uncensored 0.39 0.13 8
3.87 Uncensored 0.46 0.14 7
4.8 Uncensored 0.54 0.14 6
5.97 Uncensored 0.62 0.14 5
6.5 Censored 0.62 0.14 4
7.73 Uncensored 0.71 0.13 3
41.23 Censored 0.71 0.13 2
68.3 Censored 0.71 0.13 1
72.13 Censored 0.71 0.13 0
Table VII, online only. Kaplan-Meier survival table for ulcer recurrence
Months Status Cumulative
Standard
error At risk
0 Censored 0 0 44
0 Censored 0 0 43
0 Censored 0 0 42
1 Censored 0 0 41
1 Censored 0 0 40
1 Censored 0 0 39
3 Censored 0 0 38
3 Censored 0 0 37
9 Uncensored 0.03 0.03 36
11 Uncensored 0.05 0.04 35
12 Censored 0.05 0.04 34
13 Censored 0.05 0.04 33
13 Censored 0.05 0.04 32
18 Censored 0.05 0.04 31
20 Censored 0.05 0.04 30
20 Censored 0.05 0.05 29
21 Uncensored 0.09 0.05 28
30 Censored 0.09 0.05 27
32 Censored 0.09 0.05 26
35 Censored 0.09 0.05 25
36 Censored 0.09 0.05 24
36 Censored 0.09 0.05 23
37 Censored 0.09 0.05 22
37 Censored 0.09 0.05 21
38 Uncensored 0.13 0.06 20
38 Censored 0.13 0.06 19
38 Censored 0.13 0.06 18
39 Censored 0.13 0.06 17
41 Censored 0.13 0.06 16
42 Censored 0.13 0.06 15
44 Censored 0.13 0.06 14
47 Censored 0.13 0.06 13
49 Censored 0.13 0.06 12
49 Censored 0.13 0.06 11
60 Censored 0.13 0.06 10
62 Censored 0.13 0.06 9
65 Censored 0.13 0.06 8
66 Uncensored 0.24 0.12 7
66 Censored 0.24 0.12 6
68 Censored 0.24 0.12 5
71 Censored 0.24 0.12 4
72 Censored 0.24 0.12 3
74 Censored 0.24 0.12 2
75 Censored 0.24 0.12 1
82 Censored 0.24 0.12 0
